Tacsan, Jessel .

HRN: 26-24-38  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2024
CEFUROXIME 500MG (TAB)
11/18/2024
11/24/2024
ORAL
500 Mg
BID
Postpartum Prophylaxis; T/c UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: